K Pharma,Inc. (4896) Stock Statistics & Valuation Metrics

K Pharma,Inc. has a market cap or net worth of ¥8.01B. The enterprise value is ¥4.94B.

K Pharma,Inc. has 11,609,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

K Pharma,Inc.’s return on equity (ROE) is -0.37 and return on invested capital (ROIC) is -36.53%.

The current PE Ratio of K Pharma,Inc. is ―. K Pharma,Inc.’s PEG ratio is 0.02.

In the last 12 months, K Pharma,Inc. had revenue of 0.00 and earned -846.46M in profits. Earnings per share was -72.94.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

K Pharma,Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

K Pharma,Inc. upcoming earnings date is Feb 12, 2026, TBA (Confirmed).

K Pharma,Inc. as a current ratio of 37.00, with Debt / Equity ratio of ―

In the past 12 months, K Pharma,Inc. has paid 2.35M in taxes.

K Pharma,Inc. EV to EBITDA ratio is -5.85, with an EV/FCF ratio of -4.95.

K Pharma,Inc. has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for K Pharma,Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―